Bridgeway Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.8M | Sell |
29,157
-1,594
| -5% | -$1.62M | 0.54% | 20 |
|
|
2025
Q4 | $33M | Buy |
30,751
+385
| +1% | +$368K | 0.69% | 6 |
|
|
2025
Q3 | $23.2M | Sell |
30,366
-1,941
| -6% | -$1.44M | 0.49% | 19 |
|
|
2025
Q2 | $25.2M | Buy |
32,307
+1,348
| +4% | +$1.05M | 0.6% | 10 |
|
|
2025
Q1 | $25.6M | Buy |
30,959
+355
| +1% | +$295K | 0.64% | 8 |
|
|
2024
Q4 | $23.6M | Sell |
30,604
-2,483
| -8% | -$2.06M | 0.53% | 16 |
|
|
2024
Q3 | $29.3M | Buy |
33,087
+3,617
| +12% | +$3.25M | 0.63% | 8 |
|
|
2024
Q2 | $26.7M | Sell |
29,470
-2,506
| -8% | -$2M | 0.62% | 8 |
|
|
2024
Q1 | $24.9M | Buy |
31,976
+35
| +0.1% | +$24.9K | 0.51% | 17 |
|
|
2023
Q4 | $18.6M | Buy |
31,941
+365
| +1% | +$213K | 0.4% | 25 |
|
|
2023
Q3 | $17M | Sell |
31,576
-450
| -1% | -$232K | 0.41% | 26 |
|
|
2023
Q2 | $15M | Buy |
32,026
+23,884
| +293% | +$10M | 0.36% | 30 |
|
|
2023
Q1 | $2.8M | Sell |
8,142
-5,462
| -40% | -$1.84M | 0.07% | 438 |
|
|
2022
Q4 | $4.98M | Sell |
13,604
-5,546
| -29% | -$1.97M | 0.13% | 274 |
|
|
2022
Q3 | $6.19M | Sell |
19,150
-12,800
| -40% | -$4.06M | 0.17% | 197 |
|
|
2022
Q2 | $10.4M | Sell |
31,950
-3,800
| -11% | -$1.14M | 0.24% | 116 |
|
|
2022
Q1 | $10.2M | Sell |
35,750
-45,325
| -56% | -$11.7M | 0.2% | 160 |
|
|
2021
Q4 | $22.4M | Buy |
81,075
+60,425
| +293% | +$15.3M | 0.42% | 22 |
|
|
2021
Q3 | $4.77M | Buy |
+20,650
| New | +$5.1M | 0.09% | 331 |
|
|
2020
Q1 | – | Sell |
-2,500
| Closed | -$329K | – | 1325 |
|
|
2019
Q4 | $329K | Hold |
2,500
| – | – | ﹤0.01% | 1096 |
|
|
2019
Q3 | $280K | Sell |
2,500
-492,650
| -99% | -$54.8M | ﹤0.01% | 1109 |
|
|
2019
Q2 | $54.9M | Sell |
495,150
-35,300
| -7% | -$4.16M | 0.7% | 42 |
|
|
2019
Q1 | $68.8M | Buy |
530,450
+9,000
| +2% | +$1.09M | 0.86% | 20 |
|
|
2018
Q4 | $60.3M | Buy |
+521,450
| New | +$58.2M | 0.8% | 26 |
|
|
2016
Q2 | – | Sell |
-270,476
| Closed | -$19.5M | – | 1463 |
|
|
2016
Q1 | $19.5M | Hold |
270,476
| – | – | 0.33% | 98 |
|
|
2015
Q4 | $22.8M | Sell |
270,476
-800
| -0.3% | -$66.4K | 0.42% | 68 |
|
|
2015
Q3 | $22.7M | Sell |
271,276
-3,000
| -1% | -$253K | 0.47% | 35 |
|
|
2015
Q2 | $22.9M | Buy |
274,276
+169,376
| +161% | +$12.9M | 0.45% | 45 |
|
|
2015
Q1 | $7.62M | Buy |
+104,900
| New | +$7.47M | 0.16% | 146 |
|
|
2014
Q3 | – | Sell |
-143,730
| Closed | -$8.94M | – | 1503 |
|
|
2014
Q2 | $8.94M | Hold |
143,730
| – | – | 0.23% | 73 |
|
|
2014
Q1 | $8.46M | Sell |
143,730
-49,200
| -26% | -$2.75M | 0.24% | 66 |
|
|
2013
Q4 | $9.84M | Buy |
192,930
+126,700
| +191% | +$6.34M | 0.3% | 55 |
|
|
2013
Q3 | $3.33M | Buy |
66,230
+49,530
| +297% | +$2.59M | 0.11% | 179 |
|
|
2013
Q2 | $820K | Buy |
+16,700
| New | +$909K | 0.03% | 717 |
|
Other funds holding LLY
VCM
VPM
Bridgeway Capital Management's LLY Position: Q1 2026 in Review
Bridgeway Capital Management reduced its Eli Lilly (LLY) stake by 5.2% in Q1 2026, selling an estimated $1.62M and leaving 29,157 shares worth $26.8M. The position accounts for 0.54% of the portfolio, ranked #20.
Bridgeway Capital Management first reported a position in LLY in Q2 2013 and has held it in 34 quarters since. The position peaked at $68.8M in Q1 2019. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Bridgeway Capital Management held 29,157 shares of Eli Lilly worth $26.8M as of Q1 2026.
- Bridgeway Capital Management sold 1,594 Eli Lilly shares in Q1 2026, an estimated $1.62M.
- Eli Lilly made up 0.54% of Bridgeway Capital Management's portfolio in Q1 2026, its #20 holding.
- Bridgeway Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 34 quarters since.
- Bridgeway Capital Management's Eli Lilly position peaked at $68.8M in Q1 2019.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.